Dora Yearout

4.8k total citations · 1 hit paper
24 papers, 1.8k citations indexed

About

Dora Yearout is a scholar working on Neurology, Neurology and Cognitive Neuroscience. According to data from OpenAlex, Dora Yearout has authored 24 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 11 papers in Neurology and 5 papers in Cognitive Neuroscience. Recurrent topics in Dora Yearout's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Neurological diseases and metabolism (10 papers) and Autism Spectrum Disorder Research (5 papers). Dora Yearout is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Neurological diseases and metabolism (10 papers) and Autism Spectrum Disorder Research (5 papers). Dora Yearout collaborates with scholars based in United States, Japan and Italy. Dora Yearout's co-authors include Cyrus P. Zabetian, Ali Samii, John W. Roberts, Alida Griffith, Haydeh Payami, Denise M. Kay, Stewart A. Factor, John G. Nutt, Jennifer S. Montimurro and Berta C. Leis and has published in prestigious journals such as Nature Genetics, Neurology and Annals of Neurology.

In The Last Decade

Dora Yearout

24 papers receiving 1.8k citations

Hit Papers

Common genetic variation in the HLA region is associated ... 2010 2026 2015 2020 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dora Yearout United States 18 1.3k 624 542 487 443 24 1.8k
Alida Griffith United States 16 1.3k 1.0× 632 1.0× 541 1.0× 451 0.9× 434 1.0× 25 1.8k
Hiroyuki Tomiyama Japan 23 1.3k 1.0× 549 0.9× 614 1.1× 513 1.1× 430 1.0× 43 2.0k
Hiroyo Yoshino Japan 26 1.7k 1.3× 706 1.1× 985 1.8× 741 1.5× 478 1.1× 62 2.3k
Hiroo Yamaguchi Japan 18 1.2k 1.0× 452 0.7× 753 1.4× 904 1.9× 657 1.5× 52 2.4k
Iria Carballo‐Carbajal Spain 13 1.2k 0.9× 375 0.6× 738 1.4× 923 1.9× 469 1.1× 15 2.1k
Roberto Di Maio United States 19 752 0.6× 266 0.4× 641 1.2× 796 1.6× 365 0.8× 35 1.8k
Andreas Puschmann Sweden 24 1.0k 0.8× 282 0.5× 530 1.0× 408 0.8× 379 0.9× 57 1.6k
Emily M. Rocha United States 16 1.2k 0.9× 358 0.6× 580 1.1× 664 1.4× 689 1.6× 23 2.0k
Reema Paudel United Kingdom 16 785 0.6× 320 0.5× 521 1.0× 401 0.8× 445 1.0× 20 1.4k
Ayşe Ulusoy Germany 22 1.4k 1.0× 351 0.6× 808 1.5× 625 1.3× 415 0.9× 36 2.0k

Countries citing papers authored by Dora Yearout

Since Specialization
Citations

This map shows the geographic impact of Dora Yearout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Yearout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Yearout more than expected).

Fields of papers citing papers by Dora Yearout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dora Yearout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Yearout. The network helps show where Dora Yearout may publish in the future.

Co-authorship network of co-authors of Dora Yearout

This figure shows the co-authorship network connecting the top 25 collaborators of Dora Yearout. A scholar is included among the top collaborators of Dora Yearout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora Yearout. Dora Yearout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Velez‐Pardo, Carlos, Oswaldo Lorenzo‐Betancor, Marlene Jiménez-Del-Río, et al.. (2019). The distribution and risk effect of GBA variants in a large cohort of PD patients from Colombia and Peru. Parkinsonism & Related Disorders. 63. 204–208. 27 indexed citations
2.
Costa‐Mallen, Paola, Cyrus P. Zabetian, Shu-Ching Hu, et al.. (2016). Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease. Journal of Neural Transmission. 123(11). 1319–1330. 8 indexed citations
3.
Mata, Ignácio F., Marie Y. Davis, Michael O. Dorschner, et al.. (2016). The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 171(7). 925–930. 15 indexed citations
4.
Costa‐Mallen, Paola, Cyrus P. Zabetian, Pinky Agarwal, et al.. (2015). Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk. Parkinsonism & Related Disorders. 21(9). 1087–1092. 25 indexed citations
5.
Chahine, Lana M., Judy Qiang, Dora Yearout, et al.. (2013). Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs WithoutGBAMutations. JAMA Neurology. 70(7). 852–852. 102 indexed citations
6.
Wan, Jia Y., Karen L. Edwards, Carolyn M. Hutter, et al.. (2013). Association mapping of the PARK10 region for Parkinson's disease susceptibility genes. Parkinsonism & Related Disorders. 20(1). 93–98. 18 indexed citations
7.
Qiang, Judy, Yvette C. Wong, Andrew Siderowf, et al.. (2013). Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Annals of Neurology. 74(1). 119–127. 106 indexed citations
8.
Burns, Gully, Pritam Ganguly, Taye H. Hamza, et al.. (2012). A genetic basis for the variable effect of smoking/nicotine on Parkinson’s disease. The Pharmacogenomics Journal. 13(6). 530–537. 51 indexed citations
9.
Snapinn, Katherine W., Eric B. Larson, Hideshi Kawakami, et al.. (2011). The UCHL1 S18Y polymorphism and Parkinson’s disease in a Japanese population. Parkinsonism & Related Disorders. 17(6). 473–475. 5 indexed citations
10.
Mata, Ignácio F., Dora Yearout, Victoria Álvarez, et al.. (2011). Replication of MAPT and SNCA, but not PARK16‐18, as susceptibility genes for Parkinson's disease. Movement Disorders. 26(5). 819–823. 59 indexed citations
11.
Shi, Min, Cyrus P. Zabetian, Aneeka M. Hancock, et al.. (2010). Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neuroscience Letters. 480(1). 78–82. 173 indexed citations
12.
Hamza, Taye H., Cyrus P. Zabetian, Albert Tenesa, et al.. (2010). Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nature Genetics. 42(9). 781–785. 584 indexed citations breakdown →
13.
Poorkaj, Parvoneh, Wendy H. Raskind, James B. Leverenz, et al.. (2010). A novel X‐linked four‐repeat tauopathy with Parkinsonism and spasticity. Movement Disorders. 25(10). 1409–1417. 17 indexed citations
14.
Furlong, Clement E., Stephanie M. Suzuki, Richard Stevens, et al.. (2010). Human PON1, a biomarker of risk of disease and exposure. Chemico-Biological Interactions. 187(1-3). 355–361. 95 indexed citations
15.
Zabetian, Cyrus P., Mitsutoshi Yamamoto, Hiroshi Ujike, et al.. (2009). LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Movement Disorders. 24(7). 1034–1041. 49 indexed citations
16.
Kay, Denise M., Stewart A. Factor, Ali Samii, et al.. (2008). Genetic association between α‐synuclein and idiopathic parkinson's disease. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(7). 1222–1230. 55 indexed citations
17.
Mata, Ignácio F., Carlos Cosentino, Luis Torres, et al.. (2008). LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay. Parkinsonism & Related Disorders. 15(5). 370–373. 29 indexed citations
18.
Zabetian, Cyrus P., Carolyn M. Hutter, Stewart A. Factor, et al.. (2007). Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Annals of Neurology. 62(2). 137–144. 113 indexed citations
19.
Zabetian, Cyrus P., Carolyn M. Hutter, Dora Yearout, et al.. (2006). LRRK2 G2019S in Families with Parkinson Disease Who Originated from Europe and the Middle East: Evidence of Two Distinct Founding Events Beginning Two Millennia Ago. The American Journal of Human Genetics. 79(4). 752–758. 87 indexed citations
20.
Zabetian, Cyrus P., Hiroyuki Morino, Hiroshi Ujike, et al.. (2006). Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease. Neurology. 67(4). 697–699. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026